Startup BioNanoTech has developed a patented platform technology for purifying proteins/antibodies across size ranges. In particular, the company has developed a new class of Immobilization Metal Affinity Chromatography (IMAC) nanoresins. “We are building something new at a new scale, and something that can do chemistry and physics on a scale that is more closely to…